Senior Manager, Contracts & Pricing Strategy
Grünenthal
Senior Manager, Contracts & Pricing Strategy
Grünenthal
Global pharmaceutical company developing pain therapies
Senior Manager, Contracts & Pricing Strategy
The salary range for this position is between $150K and $185K.
Actual salary at the time of hire may vary and may be above or below the range based on various factors, including, but not limited to, the candidate’s relevant qualifications, skills, and experience. The company also currently offers a Long-Term Incentive Plan (cash plan) of 20% base salary, and Incentive compensation target of 20% (subject to meeting plan requirements).
POSITION SUMMARY
The Senior Manager, Contracts & Pricing Strategy is a strategic leader responsible for the development, execution, governance, and optimization of pharmaceutical pricing and contracting strategies across Managed Care, Commercial, Government, and Distribution channels. This role serves as a key business partner to Market Access, Finance, Legal, Commercial Operations, Revenue Management, and Payer Account teams to ensure contract structures and pricing decisions align with organizational objectives, financial targets, compliance requirements, and patient access goals.
The incumbent owns the full contract lifecycle—from strategic assessment and contract development through execution, implementation, compliance monitoring, and renewal—while driving pricing excellence and operational effectiveness. The role provides strategic insights on market trends, competitive dynamics, government pricing requirements, and gross-to-net impacts, serving as a trusted advisor to senior leadership on complex pricing and contracting decisions.
KEY RESPONSIBILITIES
Contracts & Pricing Strategy
Contract Lifecycle Management
Cross-Functional Business Partnership & Operational Excellence
Compliance, Risk Management & Governance
QUALIFICATIONS, CAREER EXPERIENCE AND SKILLS
Qualifications
Career Experience
Skills
ETHICS AND COMPLIANCE
TRAVEL
VALUES & BEHAVIORS
Global pharmaceutical company developing pain therapies
Grünenthal is a global pharmaceutical company focused on pain management. It develops, manufactures and markets prescription medicines and therapies for pain and related diseases, operating through affiliates in 28 countries with products available in about 100 countries. Its approach combines scientific research with integrated development and manufacturing to bring treatments from discovery to patient access. Medicines work by targeting pain pathways and nervous system signals through pharmacological action, supported by clinical trials and state-of-the-art technologies. The company differentiates itself by its long track record in pain care, end-to-end integration (from research and development to manufacturing and commercialization), and a global footprint that enables broad patient reach. Grünenthal’s goal is to reduce suffering from pain worldwide and improve patients’ quality of life.
Explore more opportunities at Grünenthal